BAVA.CO Gross Margin

As of 2025-05-27, the Gross Margin of Bavarian Nordic A/S (BAVA.CO) is 49.3%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

BAVA.CO Gross Margin - Historical Value

Date	Value
2024-12-31	49.3%
2023-12-31	65.2%
2022-12-31	54%
2021-12-31	30.1%
2020-12-31	36.4%
2019-12-31	46.5%
2018-12-31	49%
2017-12-31	78.8%
2016-12-31	70.4%
2015-12-31	59.3%

BAVA.CO Gross Margin - Peers Comparison

Ticker	Name	Value
ABC.L	Abcam PLC	71.1%
ALERS.PA	Eurobio Scientific SA	47.1%
ALNOV.PA	Novacyt SA	32.2%
AZT.OL	Arcticzymes Technologies ASA	94.3%
B8F.DE	Biofrontera AG	80.6%
BIO.DE	Biotest AG	30.8%
BIO.MC	Biosearch SA	39.6%
BIO.WA	Bioton SA	31.2%
BIOG B.ST	Biogaia AB	72.4%
BIOPOR.CO	Bioporto A/S	67.7%
BML.WA	Synthaverse SA	55.4%
BONEX.ST	Bonesupport Holding AB	92.6%
CIR.L	Circassia Group PLC	68.1%
COX.PA	Nicox SA	100%
DBV.PA	Dbv Technologies SA	83.6%
ERYP.PA	Erytech Pharma SA	7775.2%
HBC.OL	Hofseth Biocare ASA	34.1%
ISOFOL.ST	Isofol Medical AB (publ)	-4773.2%
OASM.ST	Oasmia Pharmaceutical AB	-6845.6%
ONCO.ST	Oncopeptides AB	91.6%
PA8.DE	Paion AG	94.1%
PHARM.AS	Pharming Group NV	88.1%
PROB.ST	Probi AB	35.1%
SANN.SW	Santhera Pharmaceuticals Holding AG	60.3%
TNG.PA	Transgene SA	-701%
VICO.ST	Vicore Pharma Holding AB	197.1%
VITR.ST	Vitrolife AB	59.3%
VLA.PA	Valneva SE	41.9%